We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Seed Innovations Limited | LSE:SEED | London | Ordinary Share | GG00BRK9BQ81 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.45 | 1.40 | 1.50 | 1.45 | 1.45 | 1.45 | 40,367 | 07:44:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | -1.11M | -2.06M | -0.0107 | -1.36 | 2.8M |
TIDMSEED
RNS Number : 5611W
Seed Innovations Limited
13 December 2023
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
13 December 2023
SEED Innovations Limited
("SEED" or the "Company")
Transaction in Own Shares & TVR
SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies to which, in normal circumstances, they have limited access to, announces that it has purchased the following number of its shares of 1p each on the London Stock Exchange to be held in treasury (through Shard Capital Stockbrokers Limited ("Shard") acting as the Company's broker).
Date of Purchase 12 December 2023 Number of shares purchased (aggregated volume): 230,000 ----------------- Highest price paid per share 2.2 pence (pence): ----------------- Lowest price paid per share 2.185 pence (pence): ----------------- Volume weighted average price 2.193478 pence paid per share (pence): -----------------
Following the purchase of these shares, the Company's issued ordinary share capital consists of 215,219,841 ordinary shares of which a total of 10,932,446 shares are held in treasury. The remaining 204,287,395 shares represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Shard on 12 December 2023 as part of the Programme as defined by the Company in the announcement on 29 September 2023.
Aggregate information:
Venue Volume-weighted average Aggregated volume price (pence per share) AIMX 2.193478 230,000 ------------------------ ------------------
Individual transactions:
Number of shares purchased Transaction Time of transaction Venue price (pence per share) 100,000 2.185 09.31.49 AIMX ----------- ------------------- ----- 130,000 2.2 15.53.29 AIMX ----------- ------------------- -----
-Ends-
For further information on the Company please visit: www.seedinnovations.co or contact: Ed McDermott SEED Innovations E: info@seedinnovations.co Lance de Jersey Ltd James Biddle Beaumont Cornish T: (0)20 7628 3396 Roland Cornish Limited, Nomad ----------------------- ------------------------------- Isabella Pierre Shard Capital Partners T: (0)20 7186 9927 Damon Heath LLP Broker ----------------------- ------------------------------- Catherine Leftley St Brides Partners E: seed@stbridespartners.co.uk Ana Ribeiro Ltd, Isabelle Morris Financial PR ----------------------- -------------------------------
Notes
Seed Innovations Ltd
SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSFFEEFEEDSELE
(END) Dow Jones Newswires
December 13, 2023 02:00 ET (07:00 GMT)
1 Year Seed Innovations Chart |
1 Month Seed Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions